Peritoneal dialysis (PD) provides convenience and flexibility for end-stage kidney disease patients. Remote-monitored APD (RM-APD) using the ShareSource platform enables real-time tracking of dialysis parameters, allowing early detection of issues during treatment. However, data on its clinical impact remain limited. This study evaluates the effect of RM-APD on compliance and clinical outcomes compared to CAPD and APD. A total of 73 PD patients (CAPD: 26, APD: 23, RM-APD: 24) were recruited from three tertiary hospitals. Baseline and one-year follow-up assessments included Kt/V, SBP, DBP, albumin, BCM, and PG-SGA score. PD compliance was evaluated using the medication possession ratio (MPR), based on prescribed and retained PD solution volumes over one year. Baseline characteristics, including age, sex, and comorbidities, were similar across groups. RM-APD had the highest compliance at 63.7% [56.6-74.1] (p=0.002), and even after adjusting for confounding variables, it remained 22.5% higher than APD (p=0.003). The number of emergency room visits over one year did not significantly differ among groups. However, RM-APD patients had 66% fewer hospitalization days than APD (p<0.001). The one-year changes in Kt/V and PG-SGA score were comparable across all groups. The OH/ECW %, an indicator of fluid overload, showed a decreasing trend in RM-APD (-1.7% [-6.6-1.1]), suggesting improved fluid management, but it was not statistically significant. RM-APD improved PD compliance and reduced hospitalization days compared to APD, while dialysis adequacy and quality of life remained similar. Further studies are needed to evaluate its long-term benefits.